Study finds high rate of overdiagnosis from mammograms

(Reuters Health) - Better treatment and not earlier detection with screening mammography may be the reason rates of death from breast cancer have declined in recent years, according to controversial results from a large U.S. database study.

In addition, the research team reports in The New England Journal of Medicine, "women were more likely to have breast cancer that was overdiagnosed than to have earlier detection of a tumor that was destined to become large."

"This new article will not change our guidelines," said Dr. Richard Wender, chief cancer control officer at the American Cancer Society, who was not involved in the new research. It is simply showing a trend, which is "the weakest form of evidence," he said.

SEE ALSO: This fish will give you nightmares

The American Cancer Society's guidelines call for women to consider having a mammogram at age 40, to actually have one each year beginning at age 45 and then, at age 55, to consider having one every other year. Wender said other medical groups have made similar recommendations.

The chief author of the new study, Dr. Gilbert Welch of the Dartmouth Institute for Health Policy and Clinical Research in Hanover, New Hampshire, and his coauthors found that mammography resulted in the discovery of 162 more cases of breast cancer for every 100,000 women, but only 30 of those small tumors were expected to grow and become a danger.

RELATED: See the risk factors associated with breast cancer

Warning signs and risk factors of breast cancer
See Gallery
Warning signs and risk factors of breast cancer

Risk factors of breast cancer: obesity

(Photo via Getty Images)

Risk factors of breast cancer: lack of exercise

(Photo by Martin Barraud, Getty Images)

Risk factors of breast cancer: alcohol use

(Photo via Ron Chapple Stock, Getty Images)

Risk factors of breast cancer: an unhealthy diet

(Photo by Dean Belcher, Getty Images)

Risk factors of breast cancer: smoking

(Photo via Getty Images)

Common signs of breast cancer: a breast mass that is hard and/or irregular 

(Photo via Getty Images)

Common signs of breast cancer: changes in the skin of the breast such as puckering, irritation, scaling, dimpling, redness or thickening

(Photo via Getty Images)

Common signs of breast cancer: swelling of all or part of the breast, even with no specific lump

(Photo via Getty Images)

Common signs of breast cancer: enlargement or swelling of the lymph nodes in the armpit area

(Photo via Getty Images)

Common signs of breast cancer: nipple discharge, that is not breast milk

(Photo via Ron Chapple Stock, Getty Images)

Common signs of breast cancer: nipple retraction, which looks like a turning inward of the nipple

(Photo via Getty Images)


Everyone should understand that there are tradeoffs in screening. It's not a simple it-can-only-help-you kind of story," he told Reuters Health.

"If you have a new breast lump you should have a mammogram. There's no doubt about that," he said. But otherwise, "women should understand it's a choice."

The debate is part of ongoing discussion about the effectiveness and timing of breast cancer screening, whether better detection technologies are identifying cancers that don't really pose a threat, and how to treat the abnormalities that are found.

"We've always been trained to think that the best test is the one that finds the most cancer," Welch said. "That's way too easy. The question is, who can find the cancers that matter? Who can help sort out what cancers are really important?"

Women who get breast cancer screening already have to deal with false positives and paying for evaluations that may not be covered by insurance, writes Dr. Joann Elmore in an accompanying editorial. Now it's becoming clear that screening is causing overdiagnosis of diseases that would never cause symptoms or death, she continues.

SEE ALSO: This is what the US election map would look like if just men voted on Election Day

"We need better methods of distinguishing biologically self-limited tumors from harmful tumors that progress," writes Elmore, a professor of medicine at the University of Washington School of Medicine in Seattle.

Wender disputes the conclusion in the new research that improved treatment, and not mammography, is responsible for the decline in breast cancer deaths.

Other studies have shown that breast screening cuts the death rate, he said. In addition, in Denmark, which embraced screening 10 years later than most Western countries, a decline in breast cancer deaths was delayed by a decade.

The data in the new study came from the U.S. national Surveillance, Epidemiology, and End Results (SEER) program.

RELATED: Spend for a cause -- Breast Cancer Awareness

Spend for a Cause: Breast Cancer Awareness
See Gallery
Spend for a Cause: Breast Cancer Awareness

Panera Bread's Pink Ribbon Bagel is back this October for a limited time, twisted in a ribbon shape in honor of Breast Cancer Awareness month.

According to the brand's website, "A portion of the proceeds from the purchase of each Pink Ribbon Bagel sold during the month of October will be donated to help the fight against Breast Cancer."

Check here for special local events, where 100 percent of the net sales will be donated.

Charm Necklace, Chloe + Isabel, $45

During the month of October, Chloe + Isabel will be donating 20 percent of proceeds from the sale of this 'candi for a cause' collection to the National Breast Cancer Foundation. 

The collection includes six different necklaces (Faith, Love, Dream, Peace, Believe, Brave). Each charm necklace holds a special meaning. 

Enjoy a $55 prix fixe dinner at Fig & Olive -- and $10 of that will go to National Breast Cancer Foundation.

Chef Wilfrid Hocquet, along with author and nutritionist, Elissa Goodman, have created a special prix fixe NBCF menu available exclusively the month of October. 

Elissa's inspiration behind the menu:

"I started off with a list of the most beneficial cancer fighting foods and was determined to include as many of these into the menu as possible, we pulled from my research of the most nutrient dense foods in the world choosing menu ingredients from the “ANDI” Guide (Aggregate Nutrient Density Index). Not only are they extremely high in cancer fighting antioxidants, but these are foods that I turned to when I was going through my diagnosis and I recommend all of my clients try to work in a minimum of 6 servings per day. 

We’ve been able to present a prix fixe menu that is maximized by superfoods and focuses on seasonality as well as the principles of Mediterranean diet, which is a high consumption of extra virgin olive oil, fruits, vegetables and fish and elimination of refined carbohydrates. The balance of protein, carbohydrates, sugar, and fiber was also taken into consideration along with portion control. We have also kept it pescatarian and have eliminated gluten and provided an option without dairy."

Tahnee Pump,, $59.95

100% of the net proceeds will go to the Susan G. Komen Foundation.

Tender Romance Pink Pony Eau de Parfum Limited Edition, Macy's, $96

100 percent of the profits of your purchase will go toward helping the Pink Pony Fund broaden access to care and reduce disparities in cancer treatment. 

Learn more here.

Shop more of the Pink Pony Collection here

Slay 02-Pink Sunglasses, PERVERSE, $50

Enter BCA2016 at checkout for 50 percent off.

25 percent of the proceeds will be donated to Breast Cancer Awareness Foundation for the entire month of October.


Over the period from 1975 to 2012, mammograms did shift the balance in how big tumors were when they were first discovered, researchers found.

The proportion of large tumors (that is, at least 2 cm in diameter) went from 64 percent to 32 percent. Over time, smaller tumors became the norm, representing 36 percent of the cancers at the start of the study period and 68 percent by the end.

Welch's team writes that the modest decrease in the number of large tumors detected over time "suggests that screening has had the desired effect of advancing the time of diagnosis of some tumors that were destined to become large." At the same time, a much larger increase in the incidence of small tumors suggests that screening has led to women being "considerably more likely to have tumors that were overdiagnosed than to have earlier detection of a tumor that was destined to become large."

The researchers estimate that at least two thirds of the reduction in deaths may be due to better treatment. But the results presume that the risk of developing breast cancer has not increased over time.

"Virtually every other expert group has concluded that, in fact, the incidence of breast cancer has been increasing," which would shift the benefit in favor of mammography, Wender noted.

Read Full Story